Cited 0 times in 
Cited 0 times in 
Phase 1 trial of vibostolimab plus pembrolizumab for PD-1/PD-L1 inhibitor-naive advanced gastric cancer: The KEYVIBE-001 trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.